CIBINQO IN ACTION
IRREGULAR IMMUNE RESPONSE
Eczema may occur because of irregular immune responses that take place within the body.
Some proteins that play a role in this overactive immune response are called JAKs. Increased JAK activity is thought to contribute to your skin becoming inflamed.
CIBINQO BLOCKS JAK1 ACTIVITY
CIBINQO is a type of eczema treatment known as a JAK inhibitor. It blocks JAK1 activity, interrupting one of the processes that leads to inflammation.
Less inflammation can mean less itch and clearer skin.
It's not currently known how inhibiting specific JAK proteins can affect eczema.
Looking for proven eczema relief?
See how CIBINQO helped provide clearer skin and itch relief for some people (ages 12 years and older) in clinical trials.
Connect with a nearby doctor
Schedule an appointment with your doctor today. If you don’t have one yet, you can find one using this tool.